COMMUNIQUÉS West-GlobeNewswire

BeiGene Initiates Phase 3 Pivotal Trial of Anti-PD-1 Antibody Tislelizumab Combined with Chemotherapy as First-Line Treatment for Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer in China
24/07/2018
BEIJING, China, and CAMBRIDGE, Mass., July 24, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted [...]
Radius Health Provides Update on Appeal of CHMP Opinion for Abaloparatide-SC
24/07/2018
WALTHAM, Mass., July 24, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq:RDUS), a science-driven fully integrated biopharmaceutical company that is committed to developing and commercializing innovative endocrine [...]
Merit Medical Announces Commencement of Public Offering of Common Stock
24/07/2018
SOUTH JORDAN, Utah, July 24, 2018 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI) (“ Merit ”), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and [...]
Kane Biotech Retains Market-Making Services
24/07/2018
WINNIPEG, Manitoba, July 24, 2018 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (OTCQB:KNBIF), (the “Corporation” or “Kane Biotech”) today announced it has, subject to regulatory approval, agreed to retain Venture [...]
FDA’s Office of Drug Evaluation III Denies Agile Therapeutics, Inc.’s Initial Formal Dispute Resolution Request
24/07/2018
Company Plans to Appeal to the FDA’s Office of New Drugs PRINCETON, N.J., July 24, 2018 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq:AGRX) (the “Company”), a women’s healthcare company, today announced that the [...]
Quotient Limited to Report Fiscal First Quarter 2019 Financial Results and Host Conference Call
24/07/2018
JERSEY, Channel Islands, July 24, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal first quarter ended June 30, 2018 [...]
argenx announces publication of full data from Phase 1 healthy volunteer study of efgartigimod in Journal of Clinical Investigation
24/07/2018
July 24, 2018 Breda, the Netherlands / Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the [...]
Sientra® to Release Second Quarter 2018 Financial Results on August 7, 2018
24/07/2018
SANTA BARBARA, Calif., July 24, 2018 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN), a medical aesthetics company (“Sientra or the “Company”), announced today that the Company will release its second quarter 2018 [...]
Nabriva Therapeutics Strengthens Antibiotics Leadership Position with Acquisition of Zavante Therapeutics
24/07/2018
- Acquisition adds Zavante’s CONTEPO ™ , potential first-in-class in the United States injectable antibiotic for cUTIs, to Nabriva’s late-stage anti-infective portfolio - - Nabriva on track to file New Drug Applications [...]
Adverum Biotechnologies Appoints Katherine Bock as Vice President, Investor Relations & Corporate Communications
24/07/2018
MENLO PARK, Calif., July 24, 2018 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (NASDAQ:ADVM), a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases, announced today [...]
TRHC Commends Progress to Expand Eligibility for MTM Services under Medicare Part D to Combat Opioid Crisis
24/07/2018
Use of Innovative MTM Technologies Encouraged for More Beneficiaries MOORESTOWN, N.J., July 24, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc . (TRHC) (NASDAQ:TRHC), a healthcare technology company advancing the [...]
Teligent, Inc. Announces FDA Approval of Hydrocortisone Cream USP, 2.5%
24/07/2018
BUENA, N.J., July 24, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new drug [...]
CFN Media Podcast -- The U.S. Cannabis Market: New Promise, Persistent Constraints
24/07/2018
SEATTLE, WA , July 24, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CannabisFN”), a leading creative agency and media network serving the global cannabis industry, today announced launch of episode number six in its [...]
CORRECTION - CFN Media - CROP Infrastructure Offers More Than Just Greenhouses to Licensed Growers
24/07/2018
CFN Media – Correction of CFN Press Release Due to Forward Looking Financial Projections SEATLLE, July 24, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated [...]
Athletic Greens Announces Rebrand of Its All-In-One Whole Food Sourced Supplement, Ultimate Daily
24/07/2018
The daily supplement packed with 75 whole food sourced ingredients is designed to enhance what you’re doing right while filling in the gaps in your diet to replenish vital nutrients NEW YORK, July 24, 2018 (GLOBE [...]
Rally Foundation for Childhood Cancer Research Makes Second Grant to National Brain Tumor Society
24/07/2018
New $100,000 grant to support Defeat Pediatric Brain Tumors Research Collaborative Boston, MA, July 24, 2018 (GLOBE NEWSWIRE) -- National Brain Tumor Society (NBTS), the largest nonprofit dedicated to the brain tumor [...]
GENFIT: INCREASE IN RESOURCES ALLOCATED TO THE LIQUIDITY CONTRACT WITH CIC
24/07/2018
GENFIT: INCREASE IN RESOURCES ALLOCATED TO THE LIQUIDITY CONTRACT WITH CIC Lille (France), Cambridge (Massachusetts, United States), July 24, 2018 - GENFIT (Euronext: GNFT - ISIN: FR0004163111), is a biopharmaceutical [...]
GENFIT : AUGMENTATION DES MOYENS ALLOUES AU CONTRAT DE LIQUIDITE CONTRACTE AVEC CIC
24/07/2018
GENFIT : AUGMENTATION DES MOYENS ALLOUES AU CONTRAT DE LIQUIDITE CONTRACTE AVEC CIC Lille (France), Cambridge (Massachusetts, Etats-Unis), le 24 juillet 2018 - GENFIT (Euronext : GNFT - ISIN : FR0004163111), société [...]
Shire plc : Director Declaration
24/07/2018
Director Declaration July 24, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company") announces that Ian Clark, Non-Executive Director of the Company, is a Non-Executive Director of Forty Seven, Inc. and AVROBIO, Inc [...]

Pages